台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    93.8
  • 漲跌
    ▼2.6
  • 漲幅
    -2.70%
  • 成交量
    206
  • 產業
    上櫃 生技醫療類股▼0.56%
  • 68人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-兆豐-桃園 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

兆豐-桃園 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/10/3000.001094.0093.80-10670-1.49%
2024/10/28197.0000.0095.5016880.15%
2024/10/232105.0000.00104.0027100.28%
2024/10/222104.0000.00107.0027260.28%
2024/10/1800.0013110.00110.00-13768-1.69%
2024/10/1600.000119.00117.0007990.00%
2024/10/01097.2000.0097.2007870.00%
2024/09/301108.0000.00108.0017770.13%
2024/09/270121.0000.00120.0007960.00%
2024/09/266134.2500.00133.0067850.76%
2024/09/251144.5000.00147.5017840.13%
2024/09/233155.172159.50158.0017940.13%
2024/09/132180.2500.00178.0027790.26%
2024/09/093184.1700.00195.0038080.37%
2024/09/061198.0000.00195.0018000.12%
2024/08/1900.001201.50201.50-1820-0.12%
2024/08/161200.5000.00200.5018220.12%
2024/08/1500.002195.00191.50-2827-0.24%
2024/08/144190.5000.00192.0048410.48%
2024/08/0800.004189.00187.00-4794-0.50%
2024/08/024178.757179.14177.50-3749-0.40%
2024/07/313160.6700.00161.0037270.41%
2024/07/2200.001175.00164.00-1667-0.15%
2024/07/199179.891178.50182.0086501.23%
2024/07/182191.501185.00196.5016110.16%
2024/07/172190.752180.75191.0005890.00%
2024/07/161174.5000.00174.5015660.18%
2024/07/1000.005152.30152.50-5512-0.97%
2024/07/0500.001129.00127.50-1480-0.21%
2024/07/036124.8300.00124.5064741.26%
2024/07/012132.5000.00137.5024350.46%
2024/06/2800.005130.00130.00-5413-1.21%
2024/06/271113.0000.00118.5013930.25%
2024/06/1100.00199.40101.50-1324-0.31%
2024/06/05196.9000.0098.6013150.32%
2024/06/03192.6000.0093.0013150.32%
2024/05/30190.5000.0090.9013200.31%
2024/05/27297.7000.00100.0023070.65%
2024/05/2300.00199.50100.50-1286-0.35%
2024/05/09176.0000.0078.0012610.38%
2024/03/040.159.7000.0060.200.11930.04%
2024/02/1600.00153.6052.00-1183-0.55%
2024/02/1500.004155.3055.50-41177-23.06%
2024/02/05250.6000.0050.5021641.22%
2024/01/302041.4600.0041.502014014.21%
2024/01/2400.00239.8539.55-2146-1.37%
2023/12/1200.000.338.0038.95-0.3221-0.14%
2023/12/1100.000.140.3539.00-0.1220-0.02%
2023/12/0800.000.140.1040.35-0.1213-0.02%
2023/12/0500.00140.1540.50-1212-0.47%
2023/11/2100.00342.7042.50-3185-1.62%
2023/11/2000.001040.9541.10-10181-5.51%
2023/11/1400.00435.0034.90-4158-2.52%
2023/11/1300.00134.4034.20-1154-0.65%
2023/10/271529.35534.1032.40101228.18%
2023/10/2600.00531.6431.00-596-5.17%
2023/10/192028.1200.0028.30207925.15%
2023/10/161524.4800.0024.55153345.34%
2023/03/2800.00121.8022.40-178-1.27%
2023/03/15119.5000.0019.501452.19%
2022/08/0300.00212.6012.40-2109-1.83%
2022/08/02112.75112.6512.5501110.00%
2022/08/01213.0000.0013.0021111.80%
2022/07/2800.00113.5013.45-1110-0.91%
2022/07/27114.1500.0014.1511090.92%
2022/04/2100.00114.9015.00-1116-0.86%
2022/04/20114.8000.0015.3511130.88%
2021/07/2100.00216.3015.85-2390-0.51%
2021/07/1200.00216.1516.05-2409-0.49%
2021/07/08116.3000.0016.1014150.24%
2021/07/07115.5000.0015.5014430.23%
2021/06/30115.6000.0015.6014710.21%
2021/06/02116.8500.0016.7014810.21%
2021/05/2700.00517.1217.40-5505-0.99%
2021/05/2600.00116.7016.70-1531-0.19%
2021/05/25316.6800.0016.5535310.56%
2021/05/21116.85116.8516.7005470.00%
2021/05/19117.1000.0016.9515470.18%
2021/05/18218.1800.0017.9025350.37%
2021/05/1300.00219.4519.55-2434-0.46%
2021/05/1200.00617.6017.80-6377-1.59%
2021/05/1100.00216.2016.20-2352-0.57%
2021/05/10116.4500.0016.5013510.28%
2021/05/06116.7000.0016.4013520.28%
2021/05/05116.45116.7016.5503510.00%
2021/05/04117.8500.0016.5013510.28%
2021/05/0300.00317.7817.60-3349-0.86%
2021/04/2900.00117.6517.60-1346-0.29%
2021/04/2800.00117.7017.75-1349-0.29%
2021/04/2700.00117.8517.80-1349-0.29%
2021/04/26117.1500.0017.3013460.29%
2021/04/23117.0500.0017.1513440.29%
2021/04/2100.00217.7517.75-2337-0.59%
2021/04/2000.00118.1517.90-1335-0.30%
2021/04/19118.0500.0018.1013350.30%
2021/04/16118.0500.0018.2013320.30%
2021/04/15517.5700.0017.6053291.52%
2021/04/14817.7900.0017.3083282.43%
2021/04/13119.3000.0018.2013220.31%
2021/04/0800.00317.1017.25-3273-1.10%
2021/04/07116.5000.0016.5512670.37%
2021/03/2500.00116.8516.55-1278-0.36%
2021/03/24116.3500.0016.8012740.36%
2021/03/10116.8500.0016.8012710.37%
2021/03/08117.25218.0017.25-1271-0.37%
2021/03/02217.6800.0017.4022560.78%
2021/02/1800.00115.2015.20-1170-0.59%
2020/12/2300.00117.9517.75-1353-0.28%
2020/12/22118.2500.0018.6513520.28%
2020/10/1300.00115.5015.40-1722-0.14%
2020/09/1600.00118.6018.55-11,367-0.07%
2020/08/2800.00120.9520.85-11,910-0.05%
2020/08/26120.9500.0020.9511,9400.05%
2020/07/3000.00124.9025.25-12,272-0.04%
2020/07/29125.7000.0025.5512,2730.04%
2020/07/2300.00129.0528.80-12,233-0.04%
2020/07/21125.70127.0027.4502,1490.00%
2020/07/2000.00123.9525.00-12,109-0.05%
2020/07/1700.00127.5526.15-12,068-0.05%
2020/07/15230.53230.6030.8001,9830.00%
2020/07/14430.35129.6529.6031,9070.16%
2020/07/1300.00131.1531.55-11,793-0.06%
2020/07/0800.00323.4023.75-31,516-0.20%
2020/07/07121.3000.0021.6011,5050.07%
2020/07/0600.00123.0523.15-11,476-0.07%
2020/07/0300.00223.6524.20-21,434-0.14%
2020/06/29122.0500.0022.3011,4060.07%
2020/06/23222.7000.0022.6021,4010.14%
2020/06/1900.003122.2022.20-311,393-2.22%
2020/06/18123.1000.0022.8511,3720.07%
2020/06/17225.40825.6125.35-61,350-0.44%
2020/06/161225.9500.0025.90121,2940.93%
2020/06/151023.65323.8224.2071,2070.58%
2020/06/121520.20221.5522.00131,1241.16%
2020/06/11320.971020.5121.00-71,077-0.65%
2020/06/1000.00718.3419.10-7985-0.71%
2020/06/0900.002017.6017.40-20958-2.09%
2020/06/04117.0000.0017.0019550.10%
2020/06/03217.30517.3517.60-3963-0.31%
2020/06/021316.8600.0016.60139661.35%
2020/06/0100.00218.7017.70-2968-0.21%
2020/05/29217.95718.7818.50-5973-0.51%
2020/05/281217.82117.7018.50119781.12%
2020/05/272323.28123.7519.45229472.32%
2020/05/26121.6000.0021.6019020.11%
2020/05/2500.00219.6019.65-2935-0.21%
2020/05/22517.03317.3017.9029300.22%
2020/05/20114.8500.0014.8518270.12%
2020/05/1900.00112.5513.50-1812-0.12%
2020/05/08112.4000.0011.8017780.13%
2020/05/0700.00112.9012.55-1767-0.13%
2020/05/06112.5500.0012.6517610.13%
2020/04/2800.00411.2911.60-4703-0.57%
2020/04/27310.5500.0010.5537020.43%
2020/04/2419.6100.009.6016960.14%
2020/03/1700.0019.009.00-1632-0.16%
2020/03/1619.78610.0110.00-5616-0.81%
2020/03/1339.3229.819.4416040.17%
2020/03/12510.641310.6810.35-8584-1.37%
2020/03/11611.64612.2311.5005630.00%
2020/03/10613.05513.6112.7515440.18%
2020/03/09414.36214.7814.1525230.38%
2020/03/06214.6500.0014.7525020.40%
2020/03/04515.5000.0014.9554591.09%
2020/03/03514.5000.0015.4554341.15%
2020/02/2700.00113.4513.30-1359-0.28%
2020/02/26113.951014.0014.05-9321-2.80%
2020/02/25112.7500.0012.8012640.38%
2020/02/2100.00110.8010.60-1182-0.55%
2020/02/18110.1000.0010.1511710.58%
2020/02/1100.00110.3510.35-1165-0.60%
2020/02/07110.4000.0010.4511670.60%
2020/02/0600.00111.1510.75-1163-0.61%
2020/02/05110.4000.0010.3511600.62%
2020/02/0400.00110.9510.80-1156-0.64%
2020/02/03110.7500.0010.3011460.68%
2019/08/2100.00110.009.92-1147-0.68%
2019/07/18112.2000.0012.2011230.81%
2019/07/1600.00111.2011.00-1104-0.96%
2019/07/12111.0500.0011.1511020.97%
2019/07/0300.00211.5011.35-290-2.21%
2019/05/23210.0000.009.8021031.94%
2019/04/16212.5000.0012.4021591.25%
2019/04/15212.4500.0012.5021601.25%
2019/04/12212.5500.0012.4521591.25%
2019/04/10212.4000.0012.4021541.30%
2019/04/01212.3000.0012.5021521.32%
2019/01/1000.00111.8511.75-169-1.44%
2019/01/0900.00111.9511.60-167-1.49%
2019/01/08212.2000.0012.202613.24%
2018/05/0300.00119.3519.35-1382-0.26%
2018/05/02119.7500.0019.6013800.26%
2018/04/2300.00220.3320.70-2363-0.55%
2018/04/19220.5000.0020.9023580.56%
2018/04/1800.00120.7019.90-1351-0.28%
2018/04/17120.6500.0020.5513420.29%
2018/04/1600.00221.4321.35-2329-0.61%
2018/04/13224.2000.0023.7023020.66%
2018/04/1100.00422.8122.90-4232-1.72%
2018/04/10222.8500.0022.8521891.05%
2018/03/2000.00119.3019.25-1187-0.53%
2018/03/16119.6500.0019.5511860.54%
2018/01/22118.7000.0018.8011910.52%
2018/01/1500.00119.4019.35-1189-0.53%
2018/01/12118.4500.0018.1511850.54%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音